The Worldwide Botulinum Toxin Industry is Expected to Reach $8.9 Billion by 2028

DUBLIN, March 21, 2022 /PRNewswire/ -- The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.

The botulinum toxin market is expected to reach US$ 8,977.62 million by 2028 from US$ 5,307.71 million in 2021. It is estimated to grow at a CAGR of 7.8% from 2021 to 2028. The factors responsible for the botulinum toxin market's growth are increasing aesthetic procedures and the use of botulinum toxin, and the rising number of non-invasive cosmetic procedures. However, the side effects of botulinum toxin hamper the market growth.

Botulinum toxins are neurotoxins that attack nerves and cause muscle paralysis. A bacterium known as clostridium botulinum makes these neurotoxins. Healthcare providers use specific bacteria for medical injections. Injections of botulinum toxin block nerve signals to the muscle injected into it. Without a signal, the muscle cannot contract. The result is a reduction in unwanted facial lines or features. Botulinum toxin injections like Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.

There is a significant rise in non-surgical procedures and dermal injectables across France. According to the Global Aesthetics Consensus, in 2016, ~258,438 non-surgical aesthetic procedures were performed in the country, out of which more than 101,400 were botulinum toxin (BTX) procedures. Moreover, the expansion of cosmetology clinics and the increase in the number of cosmetology practitioners are expected to drive the botulinum toxin market further in the coming years. People from countries, such as Switzerland, Romania, and Russia, visit France for aesthetic procedures due to advanced medical services available in the country. Moreover, in Italy, every 10th patient applying for cosmetic surgery is a tourist. The Italian Association of Aesthetic Plastic Surgery (AICPE) had announced an "aesthetic alliance" with the International Society of Aesthetic Plastic Surgery (ISAPS) to develop high-quality cosmetic surgeries with enhanced patient safety.

Similarly, according to the American Society of Plastic Surgeons (ASPS), a total of 4,401,536 botulinum toxin Type A (Botox, Dysport, Xeomin) minimally-invasive cosmetic procedures were performed in the US, in which 4,136,289 were female, and 265,247 were male. In 2020, Aesthetic Neural Network (ANN) data reported total revenue of over US$ 9 billion spent on aesthetic plastic surgery.

In addition, according to the American Society of Plastic Surgeons (ASPS), in 2019, the total number of cosmetic procedures were performed in India was 643,752, in which total non-surgical procedures were 249,024, out of which botulinum toxin procedures were 70,248. Similarly, in 2019, the total number of cosmetic procedures were performed in Brazil was 2,565,675, in which total non-surgical procedures were 1,072,002 - among them, botulinum toxin procedures were 507,869.

Therapeutic uses of BTX include treating diseases, such as chronic migraines, muscle spasticity, over-reactive bladder, and hyperhidrosis. The cosmetic and clinical application of BTX offers a comprehensive and in-depth review of aesthetic procedures and medical applications for standalone treatment, as well as combination therapy. According to ISAPS, approximately 321,702 BTX procedures were performed in Germany in 2018. Due to the increase in the geriatric population and the desire to look young, the number of BTX-based procedures being performed in Germany is on the rise.

As per ISAPS, Germany accounts for ~4% of the total number of cosmetic procedures performed worldwide. Moreover, there are more than 500 plastic surgeons in the UK, and the number is expected to increase in the future. Thus, with the rise in the number of aesthetic service providers, practitioners, and plastic surgeons, the number of aesthetic procedures performed in Europe is increasing, thereby boosting the demand and sales of botulinum toxin, which is contributing to the growth of the botulinum toxin market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global botulinum toxin market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook in North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America coupled with the factors driving the market, as well as those hindering it.
• Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Botulinum Toxin Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion

5. Botulinum Toxin Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Aesthetics Procedures and Use of Botulinum Toxin
5.1.2 Rising Number of Non-invasive Cosmetic Procedures
5.2 Market Restraints
5.2.1 Side-Effects of Botulinum Toxin
5.3 Market Opportunities
5.3.1 Increasing Therapeutic Applications of Botulinum Toxin
5.4 Future Trends
5.4.1 Rise in Product Approvals
5.5 Impact Analysis

6. Botulinum Toxin Market - Global Analysis
6.1 Global Botulinum Toxin Market Revenue Forecast and Analysis
6.2 Global Botulinum Toxin Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Global Botulinum Toxin Market Revenue and Forecasts To 2028- by Product Type
7.1 Overview
7.2 Global Botulinum Toxin Market Revenue Share, by Product Type (2021 and 2028)
7.3 Type A Botulinum Toxin
7.3.1 Overview
7.3.2 Type A Botulinum Toxin: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Type B Botulinum Toxin
7.4.1 Overview
7.4.2 Type B Botulinum Toxin: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Botulinum Toxin Market Analysis - By Application
8.1 Overview
8.2 Global Botulinum Toxin Market Revenue Share, by Application (2021 and 2028)
8.3 Medical
8.3.1 Overview
8.3.2 Medical: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Chronic Migraine
8.3.2.1.1 Overview
8.3.2.1.2 Chronic Migraine: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Muscle Spasm
8.3.2.2.1 Overview
8.3.2.2.2 Muscle Spasm: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Over Reactive Bladder
8.3.2.3.1 Overview
8.3.2.3.2 Over Reactive Bladder: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Hyperhidrosis
8.3.2.4.1 Overview
8.3.2.4.2 Hyperhidrosis: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Crow's Feet
8.4.2.1.1 Overview
8.4.2.1.2 Crow's Feet: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4.2.2 Forehead Lines
8.4.2.2.1 Overview
8.4.2.2.2 Forehead Lines: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Frown Lines/ Glabellar
8.4.2.3.1 Overview
8.4.2.3.2 Frown Lines/ Glabellar: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4.2.4 Square Jaw/ Masseter
8.4.2.4.1 Overview
8.4.2.4.2 Square Jaw/ Masseter: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Others
8.4.2.5.1 Overview
8.4.2.5.2 Others: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Botulinum Toxin Market Analysis - By End User
9.1 Overview
9.2 Global Botulinum Toxin Market Revenue Share, by End User (2021 and 2028)
9.3 Specialty and Dermatology Clinics
9.3.1 Overview
9.3.2 Specialty and Dermatology Clinics: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Clinics
9.4.1 Overview
9.4.2 Hospitals and Clinics: Global Botulinum Toxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Global botulinum toxin market - revenue and forecast to 2028 (us$ million)

10. Botulinum Toxin Market Revenue and Forecasts to 2028 - Geographical Analysis

11. Impact Of COVID-19 Pandemic on Botulinum Toxin Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Botulinum Toxin Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 AbbVie Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merz Pharma
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medytox
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ipsen Pharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Galderma
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Revance Therapeutics Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Lanzhou Institute of Biological Products Co., Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Candela Medical
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 DAEWOONG PHARMACEUTICAL CO., LTD
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/d6ky7o

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets